Quincy Chu

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

C. Gridelli, G. Ceresoli, M. Piccirillo, 2023, The Lancet.

Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process

H. Bahig, B. Melosky, B. Kidane, 2023, Current oncology.

Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC.

M. Tsao, N. Leighl, Q. Chu, 2018, Cancer treatment reviews.